Global $2.69 Billion Health Economics and Outcomes Research Services Market to 2027: Focus on Healthcare Providers, Healthcare Payers, Biotech/Pharma Companies, & Government Organizations

News provided by

Apr 30, 2021, 07:45 ET

DUBLIN, April 30, 2021 /PRNewswire/ -- The "Health Economics and Outcomes Research Services Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Service, Service Provider, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

Real-World Data Analysis and Information Systems Segment to Grow at Faster CAGR During 2020-2027

Health Economics and Outcomes Research (HEOR) Services Market is expected to reach US$ 2,699.56 million by 2027 from US$ 1,116.38 million in 2019; it is estimated to grow at a CAGR of 11.9% from 2020 to 2027.

The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the overall healthcare economics and outcomes research (HEOR) services market is attributed to increasing product development and growing healthcare spending. However, restrictions on access to real-world data (RWD) is the major factor hindering the market growth.

Based on service, the healthcare economics and outcomes research (HEOR) services market is segmented into economic modelling/evaluation, real-world data analysis and information systems, clinical outcome, and market access solutions and reimbursement.

The clinical outcome segment held the largest market share in 2019, and the real-world data analysis and information systems segment is estimated to register the highest CAGR during the forecast period. Rising number of clinical trials and growing pharmaceutical research and development activities offer lucrative opportunities for the growth of the real-world data analysis segment.

The healthcare economics and outcomes research (HEOR) services market is expected to witness substantial growth post-pandemic. The global healthcare infrastructure observed limitations and capabilities during the sudden emergence of coronavirus.

In order to deal with such situations in years to come, healthcare organizations as well as governments are expected to increase the utilization of HEOR services, which would eventually drive the market. Moreover, increase in demand for advanced data analysis technologies is anticipated to drive the market.

Companies Profiled

Axtria, Inc.
Avalon Health Economics LLC
MEDLIOR
PHARMALEX GMBH
Analysis Group
ICON PLC
IQVIA Inc.
McKESSON CORPORATION
Syneos Health
Optum, Inc.

Scope of the Report

By Service

Economic Modelling/Evaluation
Real-World Data Analysis and Information Systems
Clinical Outcome
Market Access Solutions and Reimbursement

By Service Provider

Consultancy
Contract Research Organization

By End User

Healthcare Providers
Healthcare Payers
Biotech/Pharma Companies
Government Organizations

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of APAC
Middle East & Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of MEA
South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM

For more information about this report visit https://www.researchandmarkets.com/r/9rxeah

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets